For some, biotech will be a life-saver. But Albright deftly demonstrates how the industry actually stifles innovation. Patent holders stop development of promising drugs--because the companies won't get a large enough financial reward. And the threat of costly patent infringement suits shuts down critical research. Put baldly, patents are killing people. Albright aims to set it right.
We publiceren alleen reviews die voldoen aan de voorwaarden voor reviews. Bekijk onze voorwaarden voor reviews.